Strategic Foresight in Biotechnology Firms Practice and Requirements
1 Research FocusInvestigations about the process design and degree of application of strategic foresight methods is still less investigated and discussed in the literature, especially for SMEs. Investigations a-bout the degree of the implementation of foresight methods refer predominantly to large-scale corporations (cf. Weber, 1990; Meyer-Schonherr, 1992; Burmeister, Neef, Albert, Glockner, 2002; Kreibich, Schlaffer, Trapp, Burmeister, 2002). Whether, and in what form, e. G. , scenario analysis is used in small and medium sized companies, generally remains unanswered by the investigations. To bridge this gap, 30 small and medium sized biotechnology companies were examined, within the scope of case study research. The goal of the investigation is to determine the practice of strategic foresight in these firms. How important are strategic foresight activities in the biotechnology firms? How is the early recognition of new markets and new technological developments and change carried out in the biotechnology firms? Who is responsible for strategic foresight issues and do companies use a systematic process for the early identification of new business opportunities? Which methods are used for strategic foresight? How are these methods implemented?
Dana Mietzner Guido Reger
Centre for Entrepreneurship and Innovation, University of Potsdam, Germany, Dana
国际会议
北京
英文
2-22
2008-10-16（万方平台首次上网日期，不代表论文的发表时间）